Patrys Ltd News

Patrys Ltd: Appendix 4C - Quarterly - 31 March 2024

Apr 29 19:20 ET

Patrys Ltd: Positive preclinical data for deoxymabs in vasculitis

Apr 8 19:31 ET

Patrys Ltd: Change of Director's Interest Notice

Mar 21 18:53 ET

Patrys Ltd: Notification of cessation of securities - PAB

Mar 21 18:48 ET

Patrys Ltd: Presentation to highlight broader potential of Deoxymabs

Mar 3 18:06 ET

Patrys Ltd: Appendix 4D - Half Year Accounts - 31 December 2023

Feb 22 22:51 ET

Patrys Ltd: Appendix 4C - Quarterly - 31 December 2023

Jan 22 17:52 ET

Patrys Ltd: Change of Director's Interest Notice

Dec 21, 2023 18:56 ET

Patrys Ltd: GMP Production of PAT-DX1 Next Quarter

Dec 12, 2023 17:21 ET

Patrys Ltd: Change of Director's Interest Notices x2

Nov 28, 2023 21:48 ET

Patrys Ltd: Notification of cessation of securities - PAB

Nov 28, 2023 21:42 ET

Patrys Ltd: Amended Constitution

Nov 15, 2023 01:06 ET

Patrys Ltd: Results of Annual General Meeting

Nov 15, 2023 01:00 ET

Patrys Ltd: Chair's Address and CEO Presentation to 2023 AGM

Nov 14, 2023 19:05 ET

Patrys Ltd: Notification of Expiry of PABOA Listed Options

Nov 12, 2023 17:42 ET

Patrys Ltd: Patrys Receives R&D Tax Incentive Refund

Nov 7, 2023 19:50 ET

Patrys Ltd: Appendix 4C - Quarterly - 30 September 2023

Oct 19, 2023 18:45 ET

Patrys Ltd: Data to be presented at leading brain cancer conference

Oct 18, 2023 18:40 ET

Patrys Ltd: Notice of Annual General Meeting/Proxy Form

Oct 12, 2023 00:00 ET

Patrys Ltd: Final Director's Interest Notice

Sep 20, 2023 03:45 ET